Myeloid growth factors
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2009 |
|---|---|
| Erschienen: |
2009 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Journal of the National Comprehensive Cancer Network : JNCCN - 7(2009), 1 vom: 26. Jan., Seite 64-83 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Crawford, Jeffrey [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 26.02.2009 Date Revised 17.09.2019 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM186050909 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM186050909 | ||
| 003 | DE-627 | ||
| 005 | 20231223173543.0 | ||
| 007 | tu | ||
| 008 | 231223s2009 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0620.xml |
| 035 | |a (DE-627)NLM186050909 | ||
| 035 | |a (NLM)19176207 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Crawford, Jeffrey |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Myeloid growth factors |
| 264 | 1 | |c 2009 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 26.02.2009 | ||
| 500 | |a Date Revised 17.09.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Consensus Development Conference | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Recombinant Proteins |2 NLM | |
| 650 | 7 | |a Granulocyte Colony-Stimulating Factor |2 NLM | |
| 650 | 7 | |a 143011-72-7 |2 NLM | |
| 650 | 7 | |a pegfilgrastim |2 NLM | |
| 650 | 7 | |a 3A58010674 |2 NLM | |
| 650 | 7 | |a Polyethylene Glycols |2 NLM | |
| 650 | 7 | |a 3WJQ0SDW1A |2 NLM | |
| 650 | 7 | |a sargramostim |2 NLM | |
| 650 | 7 | |a 5TAA004E22 |2 NLM | |
| 650 | 7 | |a Granulocyte-Macrophage Colony-Stimulating Factor |2 NLM | |
| 650 | 7 | |a 83869-56-1 |2 NLM | |
| 650 | 7 | |a Filgrastim |2 NLM | |
| 650 | 7 | |a PVI5M0M1GW |2 NLM | |
| 700 | 1 | |a Armitage, James |e verfasserin |4 aut | |
| 700 | 1 | |a Balducci, Lodovico |e verfasserin |4 aut | |
| 700 | 1 | |a Bennett, Charles |e verfasserin |4 aut | |
| 700 | 1 | |a Blayney, Douglas W |e verfasserin |4 aut | |
| 700 | 1 | |a Cataland, Spero R |e verfasserin |4 aut | |
| 700 | 1 | |a Dale, David C |e verfasserin |4 aut | |
| 700 | 1 | |a Demetri, George D |e verfasserin |4 aut | |
| 700 | 1 | |a Erba, Harry P |e verfasserin |4 aut | |
| 700 | 1 | |a Foran, James |e verfasserin |4 aut | |
| 700 | 1 | |a Freifeld, Alison G |e verfasserin |4 aut | |
| 700 | 1 | |a Goemann, Marti |e verfasserin |4 aut | |
| 700 | 1 | |a Heaney, Mark L |e verfasserin |4 aut | |
| 700 | 1 | |a Htoy, Sally |e verfasserin |4 aut | |
| 700 | 1 | |a Hudock, Susan |e verfasserin |4 aut | |
| 700 | 1 | |a Kloth, Dwight D |e verfasserin |4 aut | |
| 700 | 1 | |a Kuter, David J |e verfasserin |4 aut | |
| 700 | 1 | |a Lyman, Gary H |e verfasserin |4 aut | |
| 700 | 1 | |a Michaud, Laura Boehnke |e verfasserin |4 aut | |
| 700 | 1 | |a Miyata, Sarah C |e verfasserin |4 aut | |
| 700 | 1 | |a Tallman, Martin S |e verfasserin |4 aut | |
| 700 | 1 | |a Vadhan-Raj, Saroj |e verfasserin |4 aut | |
| 700 | 1 | |a Westervelt, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Michael K |e verfasserin |4 aut | |
| 700 | 0 | |a National Comprehensive Cancer Network |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the National Comprehensive Cancer Network : JNCCN |d 2003 |g 7(2009), 1 vom: 26. Jan., Seite 64-83 |w (DE-627)NLM156397676 |x 1540-1413 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2009 |g number:1 |g day:26 |g month:01 |g pages:64-83 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2009 |e 1 |b 26 |c 01 |h 64-83 | ||